Concord Medical Services Holdings (CCM) EBIT (2009 - 2025)

Concord Medical Services Holdings (CCM) has 17 years of EBIT data on file, last reported at -$20.2 million in Q2 2025.

• Quarterly EBIT rose 25.79% year-over-year to -$20.2 million in Q2 2025, while the trailing twelve-month figure through Jun 2025 was -$113.6 million (up 6.8% YoY) and the FY2025 annual result came in at -$36.9 million, up 50.23% from the prior year.
• EBIT rose to -$20.2 million in Q2 2025, from -$27.2 million in the prior quarter.
• In the past five years, EBIT ranged from a high of -$20.2 million in Q2 2025 to a low of -$36.7 million in Q2 2022.
• A 5-year average of -$28.4 million and a median of -$28.5 million in 2021 frame the typical range for EBIT.
• Annual changes were most pronounced in 2022 — EBIT fell 28.74% — and 2025, when it climbed 25.79%.
• Tracing CCM's EBIT over 5 years: stood at -$28.5 million in 2021, then dropped by 28.74% to -$36.7 million in 2022, then climbed by 19.51% to -$29.5 million in 2023, then gained by 7.81% to -$27.2 million in 2024, then rose by 25.79% to -$20.2 million in 2025.
• The last three EBIT figures came in at -$20.2 million (Q2 2025), -$27.2 million (Q2 2024), and -$29.5 million (Q2 2023), per Business Quant data.